These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Efficacy of bufexamac (NFN) cream in skin diseases. A double-blind multicentre trial.
    Author: Christiansen JV, Gadborg E, Kleiter I, Ludvigsen K, Meier CH, Norholm A, Reiter H, Reymann F, Raaschou-Nielsen W, Sondergaard M, Unna P, Wehnert R.
    Journal: Dermatologica; 1977; 154(3):177-84. PubMed ID: 140084.
    Abstract:
    The effect of a new non-steroid anti-inflammatory substance (bufexamac) in a special constituent was compared with that of 0.1% triamcinolone acetonide, 1% hydrocortisone cream, and placebo during a double-blind multicentre trial. The clinical effect of these four creams was studied in 193 patients receiving treatment for the following skin disorders: atopic dermatitis, allergic contact dermatitis, and non-allergic contact dermatitis, as well as dermatitis seborrheica. After 2 and 4 weeks' treatment, when 193 and 157 patients, respectively, were re-examined, the effect of triamcinolone acetonide and hydrocortisone cream was significantly better, than that obtained with bufexamac in the cream basis employed. On the other hand, no statistically significant difference in effect between bufexamac and placebo cream was observed.
    [Abstract] [Full Text] [Related] [New Search]